Author

Lena Peter

Observed name: Peter, Lena

Institutions: Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin

Observed institutions: Boehringer Ingelheim (Germany), Humboldt-Universität zu Berlin, German Rheumatism Research Centre, Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Einstein Center for Regenerative Therapies, Charité – Universitätsmedizin Berlin, Paul Ehrlich Institut

ORCID: 0000-0003-1205-7445

Observed ORCID: 0000-0003-1205-7445

OpenAlex ID: A5091738640

Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses

2017 · Minh-Thu Nguyen, Julia Uebele, et al. · Nature Communications · 74

Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?

2021 · Dimitrios Laurin Wagner, Lena Peter, et al. · Gene Therapy · 65

Stromal Cell-Contact Dependent PI3K and APRIL Induced NF-κB Signaling Prevent Mitochondrial- and ER Stress Induced Death of Memory Plasma Cells

2020 · Rebecca Cornelis, Stefanie Hahne, et al. · Cell Reports · 65

TGFβ links EBV to multisystem inflammatory syndrome in children

2025 · Carl Christoph Goetzke, Mona Massoud, et al. · Nature · 41

Oligoanalgesia in Patients With an Initial Glasgow Coma Scale Score ≥8 in a Physician-Staffed Helicopter Emergency Medical Service: A Multicentric Secondary Data Analysis of >100,000 Out-of-Hospital Emergency Missions

2019 · Matthias Helm, Bjoern Hossfeld, et al. · Anesthesia & Analgesia · 27

Effector memory–type regulatory T cells display phenotypic and functional instability

2024 · Désirée Jacqueline Wendering, Leila Amini, et al. · Science Advances · 24

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

2022 · Lena Peter, Désirée Jacqueline Wendering, et al. · Molecular Therapy — Methods & Clinical Development · 19

Lung tumouroids as a testing platform for precision CAR T cell therapy

2026 · Lukas Ehlen, Martí Farrera-Sal, et al. · Nature Biomedical Engineering · 9

Effects of CRISPR-Cas9-mediated FOXP3 knockout on CAR T cell potency

2025 · Lena Peter, Martí Farrera-Sal, et al. · Molecular Therapy — Methods & Clinical Development · 5

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation

2026 · Ghazaleh Zarrinrad, Lisa-Marie Burkhardt, et al. · Molecular Therapy Advances · 2

Multi-parametric profiling of IL-7-augmented GD2.CART products in a phase 1 clinical trial

2025 · Sarah Schulenberg, Martí Farrera-Sal, et al. · iScience · 2

Engineering a solution for allogeneic CAR-T rejection

2024 · Leila Amini, Lena Peter, et al. · Molecular Therapy · 1

Works count: 14

Citation count: 334

H-index: 8

I10-index: 7